Enquiry/Quote
No Image Available

Leflunomide Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg

Reference Brands:

Category: Osteoporosis

Tablet contains leflunomide. It is used to treat rheumatoid arthritis and psoriatic arthritis. Rheumatoid arthritis is an inflammatory disorder of the joints characterized by swelling, pain and difficulty moving. Loss of appetite, fever, and anemia can also occur. Psoriatic arthritis is a type of arthritis affecting people who have psoriasis. The symptoms are swelling, inflammation of joints, pain, patches of red, scaly skin, and difficulty moving.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

πŸ“˜ Sourcing Guide

Product Description: You need to inform your physician if you have a serious infection, severe kidney problems, liver problems, any disease which affects your immune system (AIDS), bone marrow disorders, or low proteins in your blood before taking Lefumide 10mg Tablet. Consult your physician if you have any intolerance to some sugars or lung disorders before starting treatment.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Related Products

Strontium Ranelate

Strength:
2 g

Form: Sachet

Reference Brands: Osseor (EU/UK)

View Details
Abaloparatide

Strength:
80 mcg

Form: injection (prefilled syringe)

Reference Brands: Tymlos (USA), Eladynos (EU)

View Details
Pamidronate Disodium

Strength:
15 mg, 30 mg, 60 mg, 90 mg

Form: Injection

Reference Brands: Aredia (USA/EU)

View Details
Calcitonin Salmon

Strength:
100 IU/mL, 200 IU/mL

Form: Injection / nasal spray

Reference Brands: Fortical (USA), Miacalcin (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.